Group 1 - The core viewpoint of the article highlights the performance and valuation of Huaxia Eye Hospital Group, noting its recent stock price increase and market position within the medical services industry [1] - As of May 6, Huaxia Eye Hospital's closing price was 19.13 yuan, with a PE ratio of 38.04, marking a 15-day low, and a total market capitalization of 16.069 billion yuan [1] - The company ranks 29th in the medical services industry, which has an average PE ratio of 38.66 and a median of 38.36 [1] Group 2 - As of the first quarter of 2025, 18 institutions hold shares in Huaxia Eye Hospital, including 10 funds, with a total holding of 192.8128 million shares valued at 3.843 billion yuan [1] - The company's main business focuses on ophthalmology services, with key products including cataract projects, posterior segment projects, refractive projects, and comprehensive optometry projects [1] - The latest financial results for the first quarter of 2025 show revenue of 1.093 billion yuan, a year-on-year increase of 11.74%, and a net profit of 150 million yuan, reflecting a year-on-year decrease of 4.00%, with a gross margin of 44.97% [1]
华厦眼科收盘上涨1.59%，滚动市盈率38.04倍，总市值160.69亿元